Oxford Performance Material Purchases PEKK Medical Business from Arkema

Share Article

Dedicated biomedical business expands in new South Windsor facility.

OXPEKK® OsteoFab™ custom implant

The new 18,000 square foot facility has expanded clean rooms suitable for polymer processing and additional fabrication technologies that OPM will be undertaking.

The founders of Oxford Performance Materials, Inc. (OPM) have acquired the PEKK medical business from Arkema, Inc. From the founding of OPM in 2002 the firm has nurtured both industrial and medical business activities. Since the acquisition by Arkema in 2009 both business units have grown rapidly. The original founders of OPM Scott DeFelice and Severine Zygmont have purchased the complete ownership of the biomedical business unit for which they have had sole management responsibility ever since the firm’s inception. The new company shall retain the name Oxford Performance Materials. Phone numbers and all other contact information remain the same.

“We are very pleased with this outcome,” said Scott DeFelice, President and CEO of OPM. “Arkema has been a great partner but the demands of the biomedical business and industrial business now require more efficient and focused structures. OPM has nurtured OXPEKK® (PEKK) for a decade and we have reached the point where the industrial activity has attained critical mass and the global resources and capabilities of Arkema are most suitable to take the business to the next level. On the other hand, the biomedical business is a very specialized, low-volume activity that is most suitable for a small, nimble organization.” In addition to the specialized nature of the biomedical business, OPM is now increasingly becoming more focused on the orthopedic sector with the development of high value-added manufacturing technologies.

As part of this reorganization OPM will be moving to a new larger facility in South Windsor, Connecticut. The new 18,000 square foot facility has expanded clean rooms suitable for polymer processing and additional fabrication technologies that OPM will be undertaking. In preparation for this move, substantial lease hold improvements are underway that will enable the firm to meet the quality and performance needs demanded by the firm’s medical clients and various regulatory bodies. The expansion project will be completed by September 2011. Further details of this expansion will be announced in the coming weeks.

About Oxford Performance Materials, Inc. (OPM)
Founded in March 2000, OPM has rapidly become an industry leader in the ultra-high performance thermoplastic polymers market. The firm's versatile OXPEKK® polymers are currently being used in medical, space and defense, semiconductor, and industrial markets worldwide. OPM was partially acquired by Arkema, Inc. in February 2009. OPM is ISO 9001:2000 and ISO 13485:2003 certified.
For additional information, please visit http://www.oxfordpm.com

About Arkema, Inc.
A global chemical company and France’s leading chemicals producer, Arkema consists of three strategically related businesses: Vinyl Products, Industrial Chemicals, and Performance Products. Arkema reported sales of 4.4 billion Euros in 2009. Arkema has 13,800 employees across 40 countries and six research centers located in France, the United States and Japan. With internationally recognized brands, Arkema holds leadership positions in its principal markets.
For additional information, please visit http://www.arkema.com

OXPEKK® is a registered trademark of Oxford Performance Materials, Inc.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Scott Defelice